未登录.png)
分享.png)
收藏分享 收藏 Risk scores predicting disease progression in early-stage CLL: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy预测早期CLL疾病进展的风险评分: IGHV子集 #2的比较分析和有用性，以提高其准确性
Arguello-Tomas, Miguel; Mozas, Pablo; Albiol, Nil; Lopez-Esteban, Miguel; Sierra, Jorge; Nomdedeu, Josep; Martinez-Laperche, Carolina; Moga, Esther; Pineyroa, Juan A.; Delgado, Julio; Osorio, Santiago; Moreno, Carol 分享 收藏 Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)在先前未经治疗的慢性淋巴细胞白血病 (CLL) 患者中，依鲁替尼继之以ofatumumab巩固: 西班牙CLL组 (GELLC) 的GELLC-7试验Abrisqueta, Pau; Gonzalez-Barca, Eva; Ferra, Christelle; Rios-Herranz, Eduardo; de la Mata, Margarita Fernandez; Delgado, Julio; Andreu, Rafael; Hernandez-Rivas, Jose angel; Terol, Maria Jose; Navarro, Almudena; Vidriales, M. Belen; Baltasar, Patricia; De la Serna, Javier; Ramirez, Angel; Ballester, Carmen; Moreno, Carol; Garcia-Marco, Jose Antonio; Cordoba, Raul; Yanez, Lucrecia; Casado, Luis Felipe; Gonzalez, Marcos; Bosch, Francesc 分享 收藏 Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLLCampanella, A.; Capasso, A.; Heltai, S.; Taccetti, C.; Albi, E.; Herishanu, Y.; Haggenburg, S.; Chatzikonstantinou, T.; Doubek, M.; Kattstrom, M.; Giannopoulos, K.; Simkovic, M.; Moreno, C.; Massaia, M.; Bumbea, H.; Alshemmari, S.; Ranghetti, P.; Perotta, E.; Martini, F.; Sant'Antonio, E.; Colia, M.; Combi, C.; Levi, S.; Kater, A. P.; Hazenberg, M.; Nijhof, I. S.; Hofsink, Q.; Demosthenous, C.; Kotaskova, J.; Zaleska, J.; Vrbacky, F.; Raya, A. Mora; Bisogno, D.; Tripoli, I. E.; Popov, V. M.; Roman, V.; Stavroyianni, N.; Karypidou, M.; Scarano, E.; Locatelli, M.; Frenquelli, M.; Scarfo, L.; Stamatopoulos, K.; Ghia, P. 分享 收藏 分享 收藏 Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE studyMoreno, Carol; Solman, Isabelle G.; Tam, Constantine S.; Grigg, Andrew; Scarfo, Lydia; Kipps, Thomas J.; Srinivasan, Srimathi; Mali, Raghuveer Singh; Zhou, Cathy; Dean, James P.; Szafer-Glusman, Edith; Choi, Michael 分享 收藏 Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature骨髓纤维化患者接受异基因供体造血细胞移植后使用减量环磷酰胺的成功结果: 挑战和文献综述Garcia-Cadenas, Irene; Redondo, Sara; Esquirol, Albert; Portos, J. M.; Novelli, Silvana; Saavedra, Silvana; Moreno, Carol; Garrido, Ana; Onate, Guadalupe; Lopez, Jordi; Caballero, Ana-Carolina; Miqueleiz, Sara; Arguello-Tomas, Miguel; Briones, Javier; Sierra, Jorge; Martino, Rodrigo 分享 收藏 Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language SummaryBarr, Paul M.; Owen, Carolyn; Robak, Tadeusz; Tedeschi, Alessandra; Bairey, Osnat; Burger, Jan A.; Hillmen, Peter; Dearden, Claire; Grosicki, Sebastian; McCarthy, Helen; Li, Jian Yong; Offner, Fritz; Moreno, Carol; Jermain, Mandy; Zhou, Cathy; Hsu, Emily; Szoke, Anita; Kipps, Thomas J.; Ghia, Paolo 分享 收藏 Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia在FCR治疗的慢性淋巴细胞白血病的真实多中心队列中，IGHV突变患者的长期益处Moia, Riccardo; Dondolin, Riccardo; De Propris, Maria Stefania; Talotta, Donatella; Mouhssine, Samir; Perutelli, Francesca; Reda, Gianluigi; Mattiello, Veronica; Rigolin, Gian Matteo; Motta, Marina; Olivieri, Jacopo; Fanin, Renato; Perbellini, Omar; Ferrarini, Isacco; Mauro, Francesca Romana; Del Giudice, Ilaria; Laurenti, Luca; Tomasso, Annamaria; Gentile, Massimo; Frustaci, Anna Maria; Tedeschi, Alessandra; Gozzetti, Alessandro; Stelitano, Caterina; Visco, Carlo; Moreno, Carol; Forconi, Francesco; Marasca, Roberto; Coscia, Marta; Rossi, Davide; Foa, Robin; Gaidano, Gianluca 分享 收藏 Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemiaBarr, Paul M.; Owen, Carolyn; Robak, Tadeusz; Tedeschi, Alessandra; Bairey, Osnat; Burger, Jan A.; Hillmen, Peter; Coutre, Steve E.; Dearden, Claire; Grosicki, Sebastian; McCarthy, Helen; Li, Jian-Yong; Offner, Fritz; Moreno, Carol; Zhou, Cathy; Hsu, Emily; Szoke, Anita; Kipps, Thomas J.; Ghia, Paolo 分享 收藏 The EHA Research Roadmap: Malignant Lymphoid DiseasesEHA研究路线图: 恶性淋巴疾病Dreyling, Martin; Andre, Marc; Gokbuget, Nicola; Tilly, Herve; Jerkeman, Mats; Gribben, John; Ferreri, Andres; Morel, Pierre; Stilgenbauer, Stephan; Fox, Christopher; Maria Ribera, Jose; Zweegman, Sonja; Aurer, Igor; Bodor, Csaba; Burkhardt, Birgit; Buske, Christian; Dollores Caballero, Maria; Campo, Elias; Chapuy, Bjoern; Davies, Andrew; de Leval, Laurence; Doorduijn, Jeanette; Federico, Massimo; Gaulard, Philippe; Gay, Francesca; Ghia, Paolo; Gronbaek, Kirsten; Goldschmidt, Hartmut; Kersten, Marie-Jose; Kiesewetter, Barbara; Landman-Parker, Judith; Le Gouill, Steven; Lenz, Georg; Leppa, Sirpa; Lopez-Guillermo, Armando; Macintyre, Elizabeth; Mantega, Maria Victoria Mateos; Moreau, Philippe; Moreno, Carol; Nadel, Bertrand; Okosun, Jessica; Owen, Roger; Pospisilova, Sarka; Pott, Christiane; Robak, Tadeusz; Spina, Michelle; Stamatopoulos, Kostas; Stary, Jan; Tarte, Karin; Tedeschi, Allessandra; Thieblemont, Catherine; Trappe, Ralf Ulrich; Trumper, Lorenz H.; Salles, Gilles 分享 收藏 分享 收藏 First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase III iLLUMINATE trialMoreno, Carol; Greil, Richard; Demirkan, Fatih; Tedeschi, Alessandra; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Novak, Jan; Strugov, Vladimir; Gill, Devinder; Gribben, John G.; Kwei, Kevin; Dai, Sandra; Hsu, Emily; Dean, James P.; Flinn, Ian W. 分享 收藏 Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and ChallengesRuxolitinib在类固醇难治性/依赖性慢性移植物抗宿主病中的疗效和安全性: 真实世界数据和挑战Redondo, Sara; Esquirol, Albert; Novelli, Silvana; Carolina Caballero, Ana; Garrido, Ana; Onate, Guadalupe; Lopez, Jordi; Moreno, Carol; Saavedra, Silvanna-Daniela; Granell, Miquel; Briones, Javier; Sierra, Jorge; Martino, Rodrigo; Garcia-Cadenas, Irene 分享 收藏 分享 收藏 Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study依鲁替尼预处理可减少CLL患者细胞因子分泌并限制obinutuzumab诱导的输注相关反应的风险: 来自illumate研究的分析Greil, Richard; Tedeschi, Alessandra; Moreno, Carol; Anz, Bertrand; Larratt, Loree; Simkovic, Martin; Gill, Devinder; Gribben, John G.; Flinn, Ian W.; Wang, Zhengyuan; Cheung, Leo W. K.; Nguyen, Aaron N.; Zhou, Cathy; Styles, Lori; Demirkan, Fatih 分享 收藏 分享 收藏 FcγRIIb-BCR co-ligation inhibits B-cell receptor signaling in chronic lymphocytic leukemiaBosch, Rosa; Mora, Alba; Cuellar, Carolina; Ferrer, Gerardo; Gorlatov, Sergey; Nomdedeu, Josep; Montserrat, Emili; Sierra, Jorge; Rai, Kanti R.; Chiorazzi, Nicholas; Moreno, Carol 分享 收藏 When an HLA identical donor is not available in adults with hematological neoplasms: single-center comparison of single-unit cord blood transplantation and haploidentical-related PBSC transplantation with PTCy using a standardized conditioning platform (thiotepa-busulfan-fludarabine)Esquirol, Albert; Querol, Sergi; Garcia-Cadenas, Irene; Novelli, Silvana; Garrido, Ana; Saavedra, Silvana; Moreno, Carol; Granell, Miquel; Caballero, Ana; Brunet, Salut; Briones, Javier; Martino, Rodrigo; Sierra, Jorge 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF HEMATOLOGY.png)
